BrightSpring Health Services (BTSG) Morgan Stanley 22nd Annual Global Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
Morgan Stanley 22nd Annual Global Healthcare Conference summary
21 Jan, 2026Strategic vision and business model
Focuses on integrated home and community health services, combining pharmacy and care delivery for seniors and behavioral populations, emphasizing high-quality, customized, and cost-effective care.
Operates in large, growing U.S. healthcare markets, leveraging a unique platform to deliver services directly to individuals in their homes or communities.
Integration of pharmacy and provider services aims to improve outcomes and efficiency for complex patient needs.
Infrastructure investments support ongoing demand and scalability for future growth.
Growth strategy and financial performance
Achieved approximately 15% annual EBITDA CAGR over eight years, with 10% organic and 5% acquisition-driven growth.
Growth driven by volume and market share gains, operational efficiencies from scale, and accretive M&A.
Pharmacy segment has outpaced provider segment in growth, but both have shown strong double-digit EBITDA increases recently.
Integrated care and home-based primary care are expected to unlock further growth and payer opportunities.
M&A and expansion initiatives
Closed six acquisitions in the current year, focusing on low-multiple, geographic tuck-ins to expand footprint.
Maintains a robust, mostly proprietary M&A pipeline, with disciplined selection to balance leverage and accretive deals.
Average pro forma EBITDA multiple for 60 deals over five years is about 4x, with recent creative structuring in Florida Hospice acquisition.
De novo expansions target 15-20 new locations annually, mainly in home health, hospice, and rehab, supporting organic growth.
Latest events from BrightSpring Health Services
- Double-digit growth and strong financial outlook driven by integration, scale, and M&A.BTSG
Investor Day 202618 Mar 2026 - AI-driven efficiency, specialty growth, and strong provider performance fuel expansion and flexibility.BTSG
Leerink Global Healthcare Conference 202610 Mar 2026 - Strong growth, margin expansion, and strategic M&A drive positive outlook despite IRA headwinds.BTSG
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - Strong 2025 growth and double-digit 2026 outlook fueled by acquisitions and efficiency.BTSG
Q4 202527 Feb 2026 - Q2 revenue up 26% to $2.73B, Adjusted EBITDA $139.1M, and guidance raised for 2024.BTSG
Q2 20242 Feb 2026 - Integrated care, operational excellence, and targeted M&A drive sustained above-market growth.BTSG
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Double-digit growth, strong Q1, and rapid M&A integration drive market leadership.BTSG
Jefferies Global Healthcare Conference1 Feb 2026 - Q3 2024 revenue up 28.8% to $2.91B, net loss narrows, and guidance raised for full year.BTSG
Q3 202417 Jan 2026 - Specialty pharmacy and oncology drive robust growth, with stable policy and diversified strategy.BTSG
Bank of America Home Care Conference11 Jan 2026